Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PelviStim is a medical technology company dedicated to developing advanced neuromodulation therapies for pelvic floor dysfunctions, specifically targeting overactive bladder (OAB). The company's core technology involves a miniaturized, implantable stimulator designed to provide targeted electrical pulses to the nerves controlling the bladder, aiming to restore normal function and improve patient quality of life. Spun out of the University of Minnesota, PelviStim focuses on creating a less invasive and more patient-friendly alternative to existing sacral nerve stimulation systems. The company is currently advancing its lead device through clinical development and regulatory pathways to address significant unmet needs in urological health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PelviStim.